person

Gala V. A.

Country
Spain
Department
ES055A: START Madrid - FJD Phase I Clinical Trials Unit

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
18
Sites with multiple studies

Has run more than one trial at 18 of 51 partner sites.

Specializations

Hematologic Malignancies

This investigator specializes in treating advanced blood cancers, with particular emphasis on Acute Myeloid Leukemia (AML) and its various presentations, including cases with measurable residual disease and specific genetic alterations.

  • AML with KMT2A or NPM1 mutations
  • Measurable Residual Disease monitoring
  • Novel therapeutic approaches for resistant AML

The investigator works with innovative treatment modalities targeting specific molecular pathways in AML.

Multiple Myeloma Research

The investigator focuses on developing treatments for relapsed or refractory multiple myeloma, exploring novel therapeutic agents and their applications in resistant disease states.

  • Advanced multiple myeloma treatments
  • Novel therapeutic compounds
  • Treatment-resistant cases

Particular attention is given to investigating first-in-human applications of new therapeutic agents.

Related Blood Disorders

The research portfolio extends to related hematologic conditions, including myelodysplastic syndrome (MDS) and AL amyloidosis, with focus on developing innovative treatment approaches.

  • Myelodysplastic neoplasms
  • Previously treated AL amyloidosis
  • Advanced treatment strategies

The investigator explores therapeutic options for patients with complex hematologic disorders requiring specialized care.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.